KOBLIZEK, Vladimir, Branislava MILENKOVIC, Michal SVOBODA, Jana KOCIANOVA, Stanislav HOLUB, Vladimir ZINDR, Miroslav ILIC, Jelena JANKOVIC, Vojislav CUPURDIJA, Jiří JARKOVSKÝ, Boris POPOV a Arschang VALIPOUR. RETRO-POPE: A Retrospective, Multicenter, Real-World Study of All-Cause Mortality in COPD. International Journal of chronic obstructive pulmonary disease. Albany: Dove Medical Press Ltd., 2023, roč. 18, November 2023, s. 2661-2672. ISSN 1178-2005. Dostupné z: https://dx.doi.org/10.2147/COPD.S426919.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název RETRO-POPE: A Retrospective, Multicenter, Real-World Study of All-Cause Mortality in COPD
Autoři KOBLIZEK, Vladimir (203 Česká republika), Branislava MILENKOVIC (203 Česká republika), Michal SVOBODA (203 Česká republika, domácí), Jana KOCIANOVA (203 Česká republika), Stanislav HOLUB (203 Česká republika), Vladimir ZINDR (203 Česká republika), Miroslav ILIC (203 Česká republika), Jelena JANKOVIC (203 Česká republika), Vojislav CUPURDIJA, Jiří JARKOVSKÝ (203 Česká republika, domácí), Boris POPOV a Arschang VALIPOUR.
Vydání International Journal of chronic obstructive pulmonary disease, Albany, Dove Medical Press Ltd. 2023, 1178-2005.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30203 Respiratory systems
Stát vydavatele Nový Zéland
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.800 v roce 2022
Kód RIV RIV/00216224:14110/23:00133349
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.2147/COPD.S426919
UT WoS 001109137500001
Klíčová slova anglicky COPD; survival; mortality; Central and Eastern Europe; respiratory; clinical phenotype; cluster
Štítky 14119612, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 31. 1. 2024 12:38.
Anotace
Purpose: The Phenotypes of COPD in Central and Eastern Europe (POPE) study assessed the prevalence and clinical characteristics of four clinical COPD phenotypes, but not mortality. This retrospective analysis of the POPE study (RETRO-POPE) investigated the relationship between all-cause mortality and patient characteristics using two grouping methods: clinical phenotyping (as in POPE) and Burgel clustering, to better identify high-risk patients.Patients and Methods: The two largest POPE study patient cohorts (Czech Republic and Serbia) were categorized into one of four clinical phenotypes (acute exacerbators [with/without chronic bronchitis], non-exacerbators, asthma-COPD overlap), and one of five Burgel clusters based on comorbidities, lung function, age, body mass index (BMI) and dyspnea (very severe comorbid, very severe respiratory, moderate-to-severe respiratory, moderate-to-severe comorbid/obese, and mild respiratory). Patients were followed-up for approximately 7 years for survival status.Results: Overall, 801 of 1,003 screened patients had sufficient data for analysis. Of these, 440 patients (54.9%) were alive and 361 (45.1%) had died at the end of follow-up. Analysis of survival by clinical phenotype showed no significant differences between the phenotypes (P=0.211). However, Burgel clustering demonstrated significant differences in survival between clusters (P<0.001), with patients in the "very severe comorbid" and "very severe respiratory" clusters most likely to die. Overall survival was not significantly different between Serbia and the Czech Republic after adjustment for age, BMI, comorbidities and forced expiratory volume in 1 second (hazard ratio [HR] 0.80, 95% confidence interval [CI] 0.65-0.99; P=0.036 [unadjusted]; HR 0.88, 95% CI 0.7-1.1; P=0.257 [adjusted]). The most common causes of death were respiratory-related (36.8%), followed by cardiovascular (25.2%) then neoplasm (15.2%).Conclusion: Patient clusters based on comorbidities, lung function, age, BMI and dyspnea were more likely to show differences in COPD mortality risk than phenotypes defined by exacerbation history and presence/absence of chronic bronchitis and/or asthmatic features.
VytisknoutZobrazeno: 19. 5. 2024 10:38